UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.76B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$447M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$336M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$294M |
| 5 |
GSK
GSK
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$937M |
| 2 |
UBS Group
UBS
|
+$511M |
| 3 |
Microsoft
MSFT
|
+$402M |
| 4 |
Baidu
BIDU
|
+$338M |
| 5 |
Apple
AAPL
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.08% |
| 2 | Consumer Discretionary | 6.75% |
| 3 | Financials | 6.3% |
| 4 | Healthcare | 5.83% |
| 5 | Industrials | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MOON
4251
DELISTED
Direxion Moonshot Innovators ETF
MOON
| $993K | ﹤0.01% |
24,195
-25,805
| -52% | -$1.07M |
|
|
EHI
4252
Western Asset Global High Income Fund
EHI
$178M
| $992K | ﹤0.01% |
94,537
-14,875
| -14% | -$152K |
|
4253
Sanmina
SANM
$10.9B
| $991K | ﹤0.01% |
23,954
-8,670
| -27% | -$315K |
|
4254
Corcept Therapeutics
CORT
$12B
| $989K | ﹤0.01% |
41,569
+621
| +2% | +$16.6K |
|
4255
Kymera Therapeutics
KYMR
$8.94B
| $989K | ﹤0.01% |
25,442
+21,829
| +604% | +$1.31M |
|
4256
Select Water Solutions
WTTR
$2.61B
| $989K | ﹤0.01% |
198,572
+1,763
| +0.9% | +$10.2K |
|
4257
Upstart Holdings
UPST
$3.03B
| $988K | ﹤0.01% |
7,673
+6,846
| +828% | +$525K |
|
4258
Costamare
CMRE
$1.77B
| $987K | ﹤0.01% |
102,581
+10,757
| +12% | +$100K |
|
|
ALBO
4259
DELISTED
Albireo Pharma Inc
ALBO
| $987K | ﹤0.01% |
28,001
+27,911
| +31,012% | +$1.03M |
|
4260
Virtus Investment Partners
VRTS
$1.1B
| $986K | ﹤0.01% |
4,184
-889
| -18% | -$214K |
|
|
SUNL
4261
CALL
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
| $986K | ﹤0.01% |
+4,715
| New | +$1.1M |
|
4262
STAAR Surgical
STAA
$1.21B
| $985K | ﹤0.01% |
9,349
-2,275
| -20% | -$228K |
|
|
ASG
4263
Liberty All-Star Growth Fund
ASG
$341M
| $984K | ﹤0.01% |
114,341
+1,113
| +1% | +$9.87K |
|
4264
US Physical Therapy
USPH
$1.22B
| $984K | ﹤0.01% |
9,449
+3,978
| +73% | +$495K |
|
4265
Central Pacific Financial
CPF
$1B
| $982K | ﹤0.01% |
36,780
-11,531
| -24% | -$263K |
|
|
EOT
4266
Eaton Vance National Municipal Opportunities Trust
EOT
$274M
| $978K | ﹤0.01% |
43,465
+2,099
| +5% | +$45K |
|
4267
Scholastic
SCHL
$792M
| $978K | ﹤0.01% |
32,491
+1,651
| +5% | +$46.5K |
|
4268
Xeris Biopharma Holdings
XERS
$1.45B
| $978K | ﹤0.01% |
216,831
+204,793
| +1,701% | +$1.1M |
|
|
EMBJ
4269
Embraer S.A. ADS
EMBJ
$13B
| $976K | ﹤0.01% |
97,506
+73,505
| +306% | +$600K |
|
4270
Everspin Technologies
MRAM
$405M
| $976K | ﹤0.01% |
162,690
+14,113
| +9% | +$83K |
|
4271
Purple Innovation
PRPL
$41.7M
| $976K | ﹤0.01% |
1,234
-239
| -16% | -$208K |
|
|
ZGNX
4272
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $976K | ﹤0.01% |
50,000
| – | – |
|
|
ICAD
4273
DELISTED
iCAD Inc
ICAD
| $972K | ﹤0.01% |
45,802
-12,673
| -22% | -$214K |
|
4274
Smith & Wesson
SWBI
$637M
| $972K | ﹤0.01% |
55,683
-10,776
| -16% | -$196K |
|
4275
CNO Financial Group
CNO
$5.1B
| $971K | ﹤0.01% |
39,939
-10,373
| -21% | -$247K |
|
Similar funds
UBS Group's Q1 2021 Portfolio in Review
As of Q1 2021, UBS Group held 9,997 positions worth $301B, up 1.9% from $296B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q1 2021 filing shows 1,505 new, 3,920 increased, 3,391 reduced and 881 closed positions. Its largest new stake was Ferguson: 1,602,252 shares worth $192M. The largest sale was Stellantis, an estimated $937M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS Group's largest Q1 2021 buy was Ferguson: 1,602,252 shares worth $192M.
- UBS Group added most to Alibaba in Q1 2021, an estimated $2.76B increase.
- UBS Group's biggest Q1 2021 reduction was Stellantis, cutting an estimated $937M.
- UBS Group fully exited Tiffany & Co. in Q1 2021, selling an estimated $77.2M.
- UBS Group's ten largest holdings make up 14% of its $301B portfolio in Q1 2021.
- UBS Group opened 1,505 new positions and closed 881 in Q1 2021.
- UBS Group's portfolio value rose 1.9% quarter-over-quarter to $301B.
Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.